BioLife Solutions, Inc.

NasdaqCM:BLFS Rapporto sulle azioni

Cap. di mercato: US$1.2b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

BioLife Solutions Gestione

Gestione criteri di controllo 2/4

BioLife Solutions' Il CEO è Rod de Greef, nominato in Oct2023, e ha un mandato di meno di un anno. la retribuzione annua totale è $ 6.39M, composta da 3.1% di stipendio e 96.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.15% delle azioni della società, per un valore di $ 1.77M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.8 anni e 15.8 anni.

Informazioni chiave

Rod de Greef

Amministratore delegato

US$6.4m

Compenso totale

Percentuale dello stipendio del CEO3.1%
Mandato del CEOless than a year
Proprietà del CEO0.1%
Durata media del management2.8yrs
Durata media del Consiglio di amministrazione15.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Investors Appear Satisfied With BioLife Solutions, Inc.'s (NASDAQ:BLFS) Prospects As Shares Rocket 28%

Aug 14
Investors Appear Satisfied With BioLife Solutions, Inc.'s (NASDAQ:BLFS) Prospects As Shares Rocket 28%

BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

Jun 20
BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

A Look At The Fair Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)

Jun 05
A Look At The Fair Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)

Revenues Not Telling The Story For BioLife Solutions, Inc. (NASDAQ:BLFS) After Shares Rise 25%

May 14
Revenues Not Telling The Story For BioLife Solutions, Inc. (NASDAQ:BLFS) After Shares Rise 25%

Broker Revenue Forecasts For BioLife Solutions, Inc. (NASDAQ:BLFS) Are Surging Higher

May 13
Broker Revenue Forecasts For BioLife Solutions, Inc. (NASDAQ:BLFS) Are Surging Higher

Should You Investigate BioLife Solutions, Inc. (NASDAQ:BLFS) At US$19.54?

May 11
Should You Investigate BioLife Solutions, Inc. (NASDAQ:BLFS) At US$19.54?

Does BioLife Solutions (NASDAQ:BLFS) Have A Healthy Balance Sheet?

Mar 12
Does BioLife Solutions (NASDAQ:BLFS) Have A Healthy Balance Sheet?

BioLife Solutions, Inc.'s (NASDAQ:BLFS) Intrinsic Value Is Potentially 64% Above Its Share Price

Feb 19
BioLife Solutions, Inc.'s (NASDAQ:BLFS) Intrinsic Value Is Potentially 64% Above Its Share Price

BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Matching Investor Opinion

Dec 19
BioLife Solutions, Inc.'s (NASDAQ:BLFS) Share Price Matching Investor Opinion

Downgrade: Here's How Analysts See BioLife Solutions, Inc. (NASDAQ:BLFS) Performing In The Near Term

Aug 17
Downgrade: Here's How Analysts See BioLife Solutions, Inc. (NASDAQ:BLFS) Performing In The Near Term

Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?

Aug 11
Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load?

Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

May 06
Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?

Feb 22
Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?

Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

Jan 10
Health Check: How Prudently Does BioLife Solutions (NASDAQ:BLFS) Use Debt?

Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?

Dec 10
Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 20% Undervaluation?

BioLife: What The Future Holds

Oct 19

BioLife Solutions COO Roderick de Greef to retire

Oct 03

BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

Sep 27
BioLife Solutions (NASDAQ:BLFS) Has Debt But No Earnings; Should You Worry?

BioLife Solutions GAAP EPS of -$1.71 misses by $1.50, revenue of $40.5M beats by $1.33M

Aug 09

BioLife Solutions: Sell-Side Posture Overly Optimistic, Rate Neutral

Jul 29

Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?

Jun 15
Is BioLife Solutions (NASDAQ:BLFS) Using Debt Sensibly?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Rod de Greef rispetto agli utili di BioLife Solutions?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-US$64m

Mar 31 2024n/an/a

-US$62m

Dec 31 2023US$6mUS$199k

-US$66m

Sep 30 2023n/an/a

-US$93m

Jun 30 2023n/an/a

-US$74m

Mar 31 2023n/an/a

-US$141m

Dec 31 2022US$2mUS$450k

-US$140m

Sep 30 2022n/an/a

-US$106m

Jun 30 2022n/an/a

-US$96m

Mar 31 2022n/an/a

-US$15m

Dec 31 2021US$1mUS$412k

-US$9m

Sep 30 2021n/an/a

US$5m

Jun 30 2021n/an/a

US$4m

Mar 31 2021n/an/a

-US$20m

Dec 31 2020US$3mUS$391k

US$2m

Sep 30 2020n/an/a

US$7m

Jun 30 2020n/an/a

US$16m

Mar 31 2020n/an/a

US$39m

Dec 31 2019US$1mUS$403k

-US$2m

Sep 30 2019n/an/a

-US$32m

Jun 30 2019n/an/a

-US$39m

Mar 31 2019n/an/a

-US$44m

Dec 31 2018US$490kUS$350k

-US$25m

Sep 30 2018n/an/a

US$1m

Jun 30 2018n/an/a

-US$146k

Mar 31 2018n/an/a

-US$2m

Dec 31 2017US$520kUS$300k

-US$3m

Compensazione vs Mercato: La retribuzione totale di Rod ($USD 6.39M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 3.30M ).

Compensazione vs guadagni: La retribuzione di Rod è aumentata nonostante l'azienda non sia redditizia.


AMMINISTRATORE DELEGATO

Rod de Greef (64 yo)

less than a year

Mandato

US$6,387,586

Compensazione

Mr. Roderick de Greef, also known as Rod, serves as Director of BioLife Solutions, Inc. since January 03, 2023 and serves as its Chief Executive Officer & Chairman since October 20, 2023. He had been Presi...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Roderick de Greef
CEO & Chairmanless than a yearUS$6.39m0.15%
$ 1.7m
Troy Wichterman
Chief Financial Officer2.8yrsUS$1.70m0.10%
$ 1.2m
Karen Foster
Chief Quality & Operations Officerless than a yearUS$1.12m0.26%
$ 3.0m
Aby Mathew
Chairman of Scientific Advisory Board4.7yrsUS$1.35m0.58%
$ 6.8m
Todd Berard
Chief Marketing Officer9.5yrsUS$734.45k0.24%
$ 2.8m
Sarah Aebersold
Chief Human Resources Officer3.6yrsNessun dato0.13%
$ 1.6m
Garrie Richardson
Chief Revenue Officerless than a yearNessun dato0.26%
$ 3.0m

2.8yrs

Durata media

52yo

Età media

Gestione esperta: Il team dirigenziale di BLFS è considerato esperto (durata media dell'incarico 2.8 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Roderick de Greef
CEO & Chairman1.6yrsUS$6.39m0.15%
$ 1.7m
Aby Mathew
Chairman of Scientific Advisory Boardno dataUS$1.35m0.58%
$ 6.8m
Shelly Heimfeld
Member of Scientific Advisory Board17.8yrsNessun datoNessun dato
Scott Burger
Member of Scientific Advisory Board16.9yrsNessun datoNessun dato
Dayong Gao
Member of Scientific Advisory Board17.8yrsNessun datoNessun dato
Andrew Hinson
Member of the Scientific Advisory Boardno dataUS$284.00kNessun dato
Erik Woods
Member of Scientific Advisory Board16.9yrsNessun datoNessun dato
Lizabeth Cardwell
Member of the Scientific Advisory Boardno dataNessun datoNessun dato
Amy DuRoss
Independent Lead Director3.3yrsUS$269.17k0.039%
$ 459.9k
Joydeep Goswami
Independent Director2.8yrsUS$250.00k0.065%
$ 755.1k
Colleen Delaney
Member of Scientific Advisory Board15.8yrsNessun datoNessun dato
John McMannis
Member of Scientific Advisory Board12.6yrsNessun datoNessun dato

15.8yrs

Durata media

58.5yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di BLFS è composto da personale esperto e esperto (durata media dell'incarico 15.8 anni).